Product Series
Cardiac & Tumor Marker Rapid Tests
Point-of-care cardiac biomarkers (troponin, CK-MB, myoglobin, D-dimer, CRP, PCT, SAA) and tumor markers (PSA, AFP, CEA) for triage and monitoring.
| SKUs | 30 |
|---|---|
| Method | colloidal-gold / FIA |
| OEM/ODM | Available — private label & custom panels |
Sub-categories
- Cardiac injury (troponin I/T, CK-MB, myoglobin, H-FABP)
- Thrombosis (D-dimer)
- Inflammation (CRP, PCT, SAA)
- Tumor markers (PSA, AFP, CEA)
Key Products (15)
Buyer angle
Hospitals, laboratories and clinics — triage-grade POC assays with fluorescence quantitative formats available.
Related comparisons
The Author's Take
Position: Position cardiac rapid tests as triage tools and tumor markers as monitoring aids — overselling either one will backfire on you and your buyers.
- POC cardiac markers are triage-grade; high-sensitivity lab assays remain the clinical standard.
- Tumor markers rise in benign conditions too — they support monitoring, not standalone diagnosis.
- Hospitals buy panels (troponin + CK-MB + myoglobin + D-dimer), so bundle rather than sell single markers.
Buyer-advisor editorial guidance — not a substitute for product IFU or local regulatory requirements.
Frequently Asked Questions
Are cardiac markers quantitative or qualitative?
Most are qualitative or semi-quantitative lateral-flow devices for triage; some markers are also available in fluorescence quantitative formats on request.
Which cardiac panel should I start with?
Troponin I + CK-MB + Myoglobin is the standard POC cardiac panel; add D-dimer for thrombosis assessment.
Are tumor markers diagnostic?
No — PSA, AFP and CEA are screening/monitoring aids that require imaging and confirmatory testing.
Need a custom panel or private label? Request a quote →
Last reviewed: 2026-09-12